Stay updated on Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:28:20.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    No additions or deletions are present for this page. The content remains unchanged.
    Difference
    0.1%
    Check dated 2026-04-09T21:01:23.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' as a condition listing and included a new Resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T14:59:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The two screenshots show no observable changes to the page content or structure; the study details page appears identical.
    Difference
    0.1%
    Check dated 2026-03-26T11:07:56.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T01:17:42.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T20:15:14.000Z thumbnail image

Stay in the know with updates to Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.